Human Amniotic Fluid

BIOLOGICAL2 trials

Sponsors

University of Utah

Conditions

SARS CoV-2SARS CoV-2 Infection

Early Phase 1

A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure

CompletedNCT04319731

University of UtahSARS CoV-2 Infection

Start: 2020-03-20End: 2020-06-09Updated: 2023-04-24

Phase 1

Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients

CompletedNCT04497389

University of UtahSARS CoV-2

Start: 2020-10-28End: 2023-02-15Updated: 2023-12-21

Related Papers

A randomized, double-blinded, placebo-controlled clinical trial of sterile filtered human amniotic fluid for treatment of COVID-19.

2023-12-08

Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial

BMJ Open2021-02-016 citations

A pilot trial of human amniotic fluid for the treatment of COVID-19.

2021-01-2210 citations